Recurrence: all 3,523 studies

Page 26 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.

• Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the PancreasStatus unknownNCT02739633Phase 2
• Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell CarcinomaStatus unknownNCT02739204Phase 2
• Adjuvant Chemotherapy With FOLFOX in HCC Patients After ResectionStatus unknownNCT02738697Phase 3
• Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell LymphomaStatus unknownNCT02733380Phase 2
• A Study of Elotuzumab With Pomalidomide, Bortezomib, and Dexamethasone in Relapsed Multiple MyelomaActive, not recruitingNCT02718833Phase 2
• Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT02718755Phase 2
• Study of Sensitization of Non-M3 AML Blasts to ATRA by Epigenetic Treatment With Tranylcypromine (TCP)Status unknownNCT02717884Phase 1/2
• Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder CancerStatus unknownNCT02716961Not applicable
• Extended Treatment Access Study of MT-3724 for Subjects With Relapsed Non-Hodgkin's B-Cell LymphomaNo longer availableNCT02715843
• A Clinical Research of CAR T Cells Targeting HER2 Positive CancerWithdrawnNCT02713984Phase 1/2
• A Study of Intravenous EEDVsMit in Children With Recurrent / Refractory Solid or CNS Tumours Expressing EGFRTerminatedNCT02687386Phase 1
• Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICECompletedNCT02686346Phase 1/2
• To Evaluate Safety and Pharmacokinetics of Belinostat in Patients Who Have Mild, Moderate and Severe Renal Impairment.TerminatedNCT02679131Phase 1
• Open-label Study of IMGN779 in Adult Patients With Relapsed/Refractory CD33-positive Acute Myeloid LeukemiaCompletedNCT02674763Phase 1
• MRD-directed Donor Lymphocyte Infusion for Reduce of Relapse After Allo-HSCTCompletedNCT02673008Phase 2/3
• Capecitabine + Bevacizumab in Patients With Recurrent GlioblastomaCompletedNCT02669173Phase 1
• Ipilimumab (Immunotherapy) and MGN1703 (TLR Agonist) in Patients With Advanced Solid MalignanciesTerminatedNCT02668770Phase 1
• Off-midline Closure Errors as a Risk Factor for Recurrence Following Limberg Flap in Patients With Pilonidal SinusCompletedNCT02663466
• Photodynamic Diagnosis (PDD) in Flexible CystoscopyCompletedNCT02660190Phase 3
• LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT02652871Phase 1
• A Study to Learn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell MalignanciesCompletedNCT02651662Phase 1
• Efficacy and Safety of Glucocorticosteroid Treatment in the Patients With Chronic Recurrent DILICompletedNCT02651350Phase 1/2
• Study Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsActive, not recruitingNCT02650401Phase 1/2
• Validation of DNA Methylation Biomarkers for Oral Cancer DetectionCompletedNCT02648789
• Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsCompletedNCT02646319Early Phase 1
• Abemaciclib in Children With DIPG or Recurrent/Refractory Solid TumorsCompletedNCT02644460Phase 1
• Non Invasive Methods for Differential Diagnosis Radionecrosis/Recurrence After Radiosurgery of Brain MetastasesCompletedNCT02636634Phase 3
• Endostar for Locally Recurrent Nasopharyngeal CarcinomaStatus unknownNCT02636231Phase 2
• Peg Interferon α-2b for Relapsed Hematological Malignancies After Allo-HSCTCompletedNCT02634294Phase 2/3
• A Study of LY2880070 in Participants With Advanced or Metastatic CancerCompletedNCT02632448Phase 1/2
• Radical Surgery Followed by Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen for the Treatment of Hepatocellular CarcinomaStatus unknownNCT02632188Phase 1/2
• Efficacy Study of TACE to Treat Hepatocellular Carcinoma After OperationStatus unknownNCT02631499Phase 4
• Phase I Study of Mitoxantrone and Etoposide Combined With Hydroxychloroquine, for Relapsed Acute Myelogenous LeukemiaTerminatedNCT02631252Phase 1
• Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or NivolumabCompletedNCT02628574Phase 1
• Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin LymphomaCompletedNCT02625480Phase 1/2
• A Novel Technique of HALS With CME and CVL for RCCStatus unknownNCT02625272Phase 2
• Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and NeckStatus unknownNCT02624128Phase 2
• CD123 Redirected Autologous T Cells for AMLTerminatedNCT02623582Early Phase 1
• A Study of Sunitinib in Patients With Metastatic or Recurrent Thymic CarcinomaCompletedNCT02623127Phase 2
• A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple MyelomaCompletedNCT02616640Phase 1
• Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal CancerTerminatedNCT02614157Not applicable
• Proof -of -Concept Study To Stratify Targeted Therapies Adapted To Molecular ProfilingCompletedNCT02613962Not applicable
• Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular CarcinomaCompletedNCT02613156
• Evaluating the Efficacy of Chloroquine for the Treatment of Plasmodium Vivax Infections in Central VietnamStatus unknownNCT02610686Phase 4
• Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized TrialStatus unknownNCT02607072Phase 3
• Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT02588456Phase 1
• Anti-recurrence Treatment of Postresection on HCC Patients With MVI Presence and Over-expression of ASPHStatus unknownNCT02587884Phase 1
• Effect of S-Adenosyl Methionine Treatment on Recurrence After Curative Resection of Hepatocellular CarcinomaStatus unknownNCT02586285Phase 1
• Cluster Headache and SPINK-1 GeneCompletedNCT02585739Not applicable
• A Study of Fibrin Sealant Plus Silver Microparticles to Prevent Incisional Hernias Following Abdominal SurgeryWithdrawnNCT02584153Phase 1
• UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD CombinationWithdrawnNCT02578121Phase 2
• Study of Carfilzomib in Multiple Myeloma Relapsed After High-dose Melphalan With Autologous Stem Cell SupportStatus unknownNCT02572492Phase 2
• An Expanded Treatment Protocol of Panobinostat in Combination Therapy for Relapsed, and Relapsed and Refractory Multiple MyelomaNo longer availableNCT02568943
• Interferon-α After DLI for the Prevention of RelapseStatus unknownNCT02568241Phase 1/2
• Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection RecurrenceStatus unknownNCT02566928Phase 4
• Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
• The Long-Term Quitting (Smoking Cessation) StudyCompletedNCT02564315Phase 4
• PET-MR-PSA Prostate Cancer Recidive StudyActive, not recruitingNCT02562131
• (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid MalignanciesCompletedNCT02561988Phase 1
• Cabazitaxel in Patients With Recurrent Ovarian Cancer After Failure of Standard Therapy.CompletedNCT02560337Phase 2
• Effect of Dissecting of The Inferior Pulmonary Ligament on Postoperative Pulmonary Reexpansion and RecurrenceStatus unknownNCT02558608Phase 3
• Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and NeckStatus unknownNCT02558387Phase 2
• Pharmacokinetics (PK), Pharmacodynamics (PD), Safety, Tolerability of Multiple Dose Regimens of MT-3724 for the Treatment of Patients With Relapsed Chronic B-cell Lymphocytic Leukemia or Small Lymphocytic LymphomaWithdrawnNCT02556346Phase 1
• NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage ChemotherapyStatus unknownNCT02544724Phase 2
• Comparison of Total Parathyroidectomy With and Without AutotransplantationStatus unknownNCT02536287Phase 3
• A Phase Ib Study of Belinostat With RDHAP Chemotherapy (Dexamethasone, Cytarabine, Cisplatinum) in Adults With Relapsed or Refractory Diffuse Large B-cell LymphomaWithdrawnNCT02532192Phase 1
• Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum MalariaCompletedNCT02528279Not applicable
• The Influence of Resection Margin on the Recurrence of Early-stage Hepatocellular CarcinomaStatus unknownNCT02525965Not applicable
• Bilateral Laparoscopic Repair of Groin Hernias With One Large Self-fixating Mesh (ProGripTM)CompletedNCT02525666
• Edmonton Symptom Assessment Scale: Self-Completion vs. Assisted-CompletionCompletedNCT02523378Not applicable
• Effect of Intraoperative Controlled Release 5-Fluorouracil Therapy on Recurrence in Hepatocellular Carcinoma PatientsStatus unknownNCT02523053Not applicable
• Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic LeukemiaCompletedNCT02520895
• Comparison of LCBDE vs ERCP + LC for CholedocholithiasisCompletedNCT02515474Not applicable
• Comparison DW-MRI vs FDG PET/CT in the Detection of Early Recurrence of Cervical Well-differentiated Thyroid CarcinomaCompletedNCT02515084Phase 2
• Carfilzomib in Combination With Cyclophosphamide and Etoposide for ChildrenCompletedNCT02512926Phase 1
• Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLCCompletedNCT02492568Phase 2
• Effectiveness of Chemotherapy in Metastatic or Recurrent Carcinoma CervixStatus unknownNCT02492503Phase 1/2
• Peptide Receptor Radionuclide Therapy With 90Y-Dotatoc in Relapsed/Refractory Diffuse Large B Cell and Mantle Cell LymphomasTerminatedNCT02488512Phase 2
• Two-week Course Versus Conventionally Fractionated Chemoradiotherapy in Rectal CancerStatus unknownNCT02484040Phase 3
• A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)Active, not recruitingNCT02483312Phase 1
• Vaccine Enriched, Autologous, Activated T-Cells Directed to Tumor in Patients With Relapsed/Refractory MelanomaCompletedNCT02482532Phase 1
• A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal CarcinomatosisCompletedNCT02475772Phase 1
• the Influence of General Anesthesia on Tumor Metastasis and RecurrenceStatus unknownNCT02474511
• Intravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBTStatus unknownNCT02471547Not applicable
• NMP in Relapsed / Refractory MyelomaCompletedNCT02468687Phase 1
• Breast-Conserving Therapy in Patients With Triple-Negative Breast CancerStatus unknownNCT02464774Not applicable
• Phase II Randomised Trial of Cyclophosphamide & Dexamethasone in Combination With Ixazomib in Relapsed or Refractory Multiple Myeloma.CompletedNCT02461888Phase 2
• Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung CancerTerminatedNCT02460367Phase 1
• MRI Imaging of Retromuscular Hernia Repair With CICAT Visible®Status unknownNCT02460029
• Study of Treatment Response on IgG4 Related Disease (IgG4RD)Status unknownNCT02458196Phase 2
• Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and ProgressionStatus unknownNCT02443844Phase 4
• Host Immune Response to Clostridium Difficile Infection (ICD)CompletedNCT02440438Not applicable
• Longitudinal Analysis And Sample Collection To Evaluate PML Risk Host Markers for PML Risk Host Markers for PML RiskCompletedNCT02440126
• Early Access Program (EAP) for Ibrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Approved for marketingNCT02437019
• p53 Gene in Treatment of Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, and Primary Peritoneal CancerStatus unknownNCT02435186Phase 2
• Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic TransplantationCompletedNCT02431988Phase 1
• Study of LEE011plus Cetuximab in Patients With a Cancer of the Head and NeckTerminatedNCT02429089Phase 1
• Evaluation of the Relapse Rate One Month After Discharge From Emergency Department for Asthmatic Patients Given a Strict Formalized Follow up ProtocolCompletedNCT02424409Not applicable
• Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose AspirinCompletedNCT02423187
• Changes in Patient Reported Constipation Among Advanced Cancer Patients After Receiving an Educational InterventionCompletedNCT02422329Not applicable

← Recurrence overview